Brenda Mc Carthy
About Brenda Mc Carthy
Brenda McCarthy is a Senior Pharmacovigilance Scientist at Deciphera Pharmaceuticals, with a background in nursing and clinical research. She has extensive experience in pharmacovigilance and clinical safety, having worked in various roles within the pharmaceutical and healthcare sectors.
Current Role as Senior Pharmacovigilance Scientist
Brenda McCarthy currently serves as a Senior Pharmacovigilance Scientist at Deciphera Pharmaceuticals. She has held this position since 2023. In this role, she is responsible for monitoring and evaluating the safety of pharmaceutical products, ensuring compliance with regulatory requirements, and contributing to the overall pharmacovigilance strategy of the organization.
Experience at Deciphera Pharmaceuticals
Brenda McCarthy has extensive experience at Deciphera Pharmaceuticals. She initially joined the company as an Associate Pharmacovigilance Scientist in 2020 and worked in this role until 2022. Following this position, she advanced to Pharmacovigilance Scientist from 2022 to 2023 before her current role. Her tenure at Deciphera has involved various responsibilities related to drug safety and risk management.
Previous Experience in Clinical Safety
Before her time at Deciphera Pharmaceuticals, Brenda McCarthy worked at Medpace as a Clinical Safety Coordinator II from 2019 to 2020 and as a Clinical Safety Coordinator I from 2018 to 2019. In these roles, she focused on ensuring the safety of clinical trial participants and managing adverse event reporting.
Nursing Background
Brenda McCarthy began her career in healthcare as a Registered Nurse at Cincinnati Children's Hospital Medical Center, where she worked from 2017 to 2018. This experience provided her with a solid foundation in patient care and clinical practices, which she later applied in her pharmacovigilance roles.
Educational Qualifications
Brenda McCarthy holds a Master of Science in Clinical Research from the Massachusetts College of Pharmacy and Health Sciences, which she completed from 2022 to 2023. She also earned a Bachelor of Science in Nursing from Xavier University, where she studied from 2013 to 2017. Her educational background supports her expertise in both clinical and pharmacovigilance settings.